Cannabidiol for Behavioural Symptoms in Alzheimer's Disease | C4C
To evaluate the feasibility of conducting a future fully powered randomised clinical trial (RCT) to investigate whether cannabidiol (CBD) added to treatment as usual, in people with Alzheimer’s disease (AD) and Behavioural and Psychological Symptoms of Dementia (BPSD) is safe and tolerated well and can alleviate BPSD symptoms.